The New Dawn

In the inaugural episode of The Quantum Leap, Dr. Nirdosh Jagota presents a strategic and forward-looking examination of the AI-native pharmaceutical enterprise—a fundamental departure from the traditional drug development model. Drawing on over three decades of global experience in biotechnology and regulatory leadership, Dr. Jagota analyzes the structural limitations of the current R&D paradigm, including escalating development costs, extended timelines, and high clinical attrition rates.

This episode introduces the defining pillars of the AI-native organization: data as a core asset, end-to-end AI platforms, and automated closed-loop laboratories. Through case studies involving industry leaders such as Eli Lilly, Novartis, Insilico Medicine, Recursion, and Exscientia, Dr. Jagota explores how integrated data architectures, machine learning-driven discovery engines, and robotics-enabled experimentation are reshaping the economics and physics of drug development.

He further evaluates the strategic responses of established pharmaceutical companies—builders, network orchestrators, and enterprise optimizers—highlighting the competitive necessity of AI adoption across the value chain.

This foundational discussion establishes the conceptual framework for the series, offering a rigorous perspective on how AI is transforming not only scientific workflows but also business models, talent requirements, and investment strategies within the life sciences sector.

For extended analysis, publications, and Dr. Jagota’s broader thought leadership, please visit: 🌐 https://nirdoshjagota.us/

🌐 https://nirdoshjagota.net/

🌐 https://nirdoshjagota.com/

🌐 https://aboutnirdoshjagota.com/

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(16)

2040: A Day in the Life

What could an ordinary day in medicine look like in the year 2040? In the season finale of The Quantum Leap, Dr. Nirdosh Jagota imagines a single day in a future shaped by artificial intelligence, gen...

16 Syys 15min

The Great Integration

How Big Pharma Is Adopting, Acquiring, and Competing with Deep Tech What does a century-old pharmaceutical company do when the future arrives from a technology company? In this episode of The Quantum ...

16 Syys 14min

The Sentient Supply Chain

In this episode of The Quantum Leap, Dr. Nirdosh Jagota steps onto the pharmaceutical factory floor to examine how artificial intelligence, advanced optimization, continuous manufacturing, and digital...

17 Elo 13min

The Black Box Dilemma

In this episode of The Quantum Leap, Dr. Nirdosh Jagota examines one of the most important challenges facing AI and quantum medicine: how clinicians, regulators, and patients can trust decisions produ...

17 Elo 12min

The Quantum Doctor

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores how quantum computing could move beyond pharmaceutical research and into hospitals, diagnostics, genomics, and personalized patient car...

24 Heinä 8min

Solving the Unsolvable

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most exciting frontiers in pharmaceutical innovation: quantum simulation. Building on the foundation of quantum computing in...

24 Heinä 9min

The Quantum Dawn

In this milestone episode of The Quantum Leap, Dr. Nirdosh Jagota introduces one of the most transformative technologies on the horizon: quantum computing. As artificial intelligence continues to resh...

15 Kesä 8min

The New AI Scientist

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most profound shifts in the history of scientific discovery: the emergence of AI as an active research partner. Moving beyon...

15 Kesä 9min